Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Alkermes Climbs as FDA Accepts New Drug Application Resubmission
By Tony Owusu
Dec 29, 2020 10:23 AM EST
PRESS RELEASES
Alkermes To Present At The 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 6, 2021 4:00 PM EST
INVESTING
Alkermes Climbs as FDA Accepts New Drug Application Resubmission
By Tony Owusu
Dec 29, 2020 10:23 AM EST
PRESS RELEASES
Alkermes Presents New Data On ALKS 4230 At Society For Immunotherapy Of Cancer's (SITC) 35th Anniversary Annual Meeting
By PR Newswire
Nov 9, 2020 8:01 AM EST
PRESS RELEASES
Alkermes Reschedules Third Quarter 2020 Financial Results Conference Call To 10:30 A.m. ET
By PR Newswire
Oct 29, 2020 10:24 AM EDT
PRESS RELEASES
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board Of Directors
By Business Wire
Oct 28, 2020 4:05 PM EDT
PRESS RELEASES
Alkermes To Host Conference Call To Discuss Third Quarter 2020 Financial Results
By PR Newswire
Oct 22, 2020 4:00 PM EDT
PRESS RELEASES
FDA Advisory Committee Votes In Support Of ALKS 3831 For The Treatment Of Schizophrenia And Bipolar I Disorder
By PR Newswire
Oct 9, 2020 5:11 PM EDT
PRESS RELEASES
Alkermes Announces Posting Of Briefing Documents For FDA Advisory Committee Meeting On ALKS 3831
By PR Newswire
Oct 7, 2020 10:14 AM EDT
PRESS RELEASES
Alkermes Presents New Clinical Data On ALKS 4230 In Mini Oral Presentation At 2020 European Society For Medical Oncology (ESMO) Virtual Congress
By PR Newswire
Sep 18, 2020 6:30 AM EDT
PRESS RELEASES
Alkermes To Take Part In Cantor Virtual Global Healthcare Conference
By PR Newswire
Sep 9, 2020 4:00 PM EDT
PRESS RELEASES
Alkermes To Present New Data On Investigational Immuno-Oncology Candidate, ALKS 4230, At The 2020 European Society For Medical Oncology (ESMO) Virtual Congress
By PR Newswire
Sep 8, 2020 7:00 AM EDT
PRESS RELEASES
Alkermes Initiates Phase 2 Study Designed To Evaluate Clinical And Immunologic Activity Of ALKS 4230 On Tumor Microenvironment In Patients With Advanced Solid Tumors
By PR Newswire
Aug 19, 2020 7:00 AM EDT
PRESS RELEASES
Alkermes To Host Conference Call To Discuss Second Quarter 2020 Financial Results
By PR Newswire
Jul 22, 2020 4:00 PM EDT
PRESS RELEASES
Alkermes Announces Launch Of 3rd Annual Alkermes Pathways Research Awards® Program
By PR Newswire
Jun 29, 2020 7:00 AM EDT
PRESS RELEASES
Alkermes To Take Part In 41st Annual Goldman Sachs Global Healthcare Conference
By PR Newswire
Jun 4, 2020 4:00 PM EDT
PRESS RELEASES
Alkermes Announces Upcoming Presentation At The Bank Of America Securities Virtual Health Care Conference
By PR Newswire
May 6, 2020 4:00 PM EDT
PRESS RELEASES
Alkermes Launches COVID-19 Relief Fund To Support Innovative Programs Helping Vulnerable Patient Communities
By PR Newswire
May 4, 2020 7:00 AM EDT
PRESS RELEASES
Alkermes To Host Conference Call To Discuss First Quarter 2020 Financial Results
By PR Newswire
Apr 22, 2020 4:00 PM EDT
PRESS RELEASES
Alkermes Announces Publication Of Preclinical Data For ALKS 4230 In The Journal For ImmunoTherapy Of Cancer
By PR Newswire
Apr 22, 2020 7:00 AM EDT
PRESS RELEASES
Journal Of Clinical Psychiatry Publishes Data From Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study Of ALKS 3831 In Patients With Schizophrenia
By PR Newswire
Mar 4, 2020 7:00 AM EST
PRESS RELEASES
Alkermes' Corporate Presentation To Be Webcast At The Cowen And Company 40th Annual Health Care Conference
By PR Newswire
Feb 24, 2020 4:00 PM EST
PRESS RELEASES
Alkermes To Present At The 9th Annual SVB Leerink Global Healthcare Conference
By PR Newswire
Feb 19, 2020 4:01 PM EST
PRESS RELEASES
Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2019 Financial Results
By PR Newswire
Feb 6, 2020 4:00 PM EST
PRESS RELEASES
Alkermes' Corporate Presentation To Be Webcast At The 38th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 8, 2020 11:00 AM EST
